New mouse model for testing cancer drugs

Only one in twenty cancer drugs makes its way from the laboratory to the market. The majority of new agents are only shown to be unsuitable in the later phases of clinical development which would explain the exorbitantly high development costs. A new mouse model could help researchers to recognize effects and side effects at an earlier stage.

Read the whole article on Science Daily

More from Science Daily